Green Cross Medical Science Past Earnings Performance
Past criteria checks 2/6
Green Cross Medical Science has been growing earnings at an average annual rate of 15.1%, while the Medical Equipment industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 1.6% per year. Green Cross Medical Science's return on equity is 3.1%, and it has net margins of 1.2%.
Key information
15.1%
Earnings growth rate
33.2%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 1.6% |
Return on equity | 3.1% |
Net Margin | 1.2% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated
Mar 26Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings
Mar 23Recent updates
Is Green Cross Medical Science (KOSDAQ:142280) A Risky Investment?
Aug 30There's No Escaping Green Cross Medical Science Corporation's (KOSDAQ:142280) Muted Revenues Despite A 45% Share Price Rise
Aug 08We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated
Mar 26Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings
Mar 23These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively
Feb 24Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?
Jan 28Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?
Jan 02Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?
Dec 07Revenue & Expenses Breakdown
How Green Cross Medical Science makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 96,291 | 1,176 | 8,558 | 3,050 |
31 Mar 24 | 94,307 | 1,093 | 8,633 | 2,751 |
31 Dec 23 | 94,011 | 1,797 | 8,503 | 2,880 |
30 Sep 23 | 97,968 | -1,470 | 12,039 | 2,780 |
30 Jun 23 | 98,890 | 1,185 | 12,646 | 2,772 |
31 Mar 23 | 92,651 | 945 | 10,117 | 2,595 |
31 Dec 22 | 113,109 | -3,581 | 11,205 | 2,167 |
30 Sep 22 | 97,543 | -19,947 | 9,952 | 2,015 |
30 Jun 22 | 99,135 | -26,732 | 13,698 | 1,982 |
31 Mar 22 | 122,852 | -25,192 | 18,425 | 2,037 |
31 Dec 21 | 101,675 | -21,202 | 18,608 | 2,134 |
30 Sep 21 | 122,729 | 2,285 | 17,673 | 2,407 |
30 Jun 21 | 126,536 | 5,724 | 14,826 | 2,508 |
31 Mar 21 | 114,468 | 7,328 | 13,044 | 2,691 |
31 Dec 20 | 113,377 | 6,554 | 11,948 | 2,654 |
30 Sep 20 | 103,077 | 1,686 | 9,940 | 2,504 |
30 Jun 20 | 91,897 | 517 | 9,152 | 2,390 |
31 Mar 20 | 84,430 | -9,592 | 9,031 | 2,196 |
31 Dec 19 | 81,493 | -11,226 | 9,320 | 2,188 |
30 Sep 19 | 81,306 | -13,447 | 9,902 | 2,066 |
30 Jun 19 | 84,003 | -15,659 | 10,397 | 2,102 |
31 Mar 19 | 85,913 | -10,194 | 10,673 | 2,087 |
31 Dec 18 | 86,322 | -10,711 | 11,282 | 2,058 |
30 Sep 18 | 88,457 | -9,276 | 12,120 | 1,960 |
30 Jun 18 | 92,921 | -6,394 | 12,530 | 1,790 |
31 Mar 18 | 94,750 | -3,995 | 12,669 | 1,777 |
31 Dec 17 | 98,389 | -1,348 | 12,379 | 1,818 |
30 Sep 17 | 95,795 | 613 | 12,570 | 1,884 |
30 Jun 17 | 90,728 | -236 | 11,925 | 1,994 |
31 Mar 17 | 88,887 | -899 | 11,613 | 1,888 |
31 Dec 16 | 86,163 | -1,891 | 11,692 | 1,653 |
30 Sep 16 | 86,656 | -2,701 | 10,583 | 1,589 |
30 Jun 16 | 89,432 | -1,277 | 10,707 | 1,438 |
31 Mar 16 | 89,028 | -21 | 10,373 | 1,238 |
31 Dec 15 | 89,298 | 729 | 9,886 | 1,146 |
30 Sep 15 | 88,052 | 2,935 | 9,753 | 975 |
31 Dec 14 | 81,335 | 3,717 | 8,772 | 1,018 |
Quality Earnings: A142280 has a large one-off loss of ₩584.3M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: A142280's current net profit margins (1.2%) are higher than last year (1.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A142280 has become profitable over the past 5 years, growing earnings by 15.1% per year.
Accelerating Growth: A142280's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A142280 had negative earnings growth (-0.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-2.3%).
Return on Equity
High ROE: A142280's Return on Equity (3.1%) is considered low.